AC1903, A small-molecule inhibitor of TRPC5, suppressed severe proteinuria and prevented podocyte loss in a rat model of hypertensive proteinuric kidney disease, which indicates TRPC5 inhibitors may be valuable for the treatment of progressive kidney diseases [37]. This evidence concerns the gene TRPC5 and kidney disorder.